CAS: 88931-51-5; Isocarbacyclin

该化合物是一个复杂的有机化合物,其特点是复杂的立体化学和多种功能组.该物质具有六氢五氢结构,表明一个混合的双循环系统,有助于其独特的化学特性.氢氧化合物的存在表明氢联结的潜力,影响其溶性与再活动.此外,长的碳氢化合物链(环球体组)可能会产生缺水的特性,影响其在生物系统中的相互作用.由特定气管中心表示的立体化学结构在确定该化合物的生物活动和药理特性方面发挥着关键作用.这些化合物由于其潜在的治疗用途,往往对医药化学和天然产品合成感兴趣.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      📜<3As-<3Aα,4α(1E,3R*),5β,6Aα>>-Methyl 5-Pentanoate置于三氟乙酸体系中,用 二氯甲烷 作为反应溶剂,化学反应 14.5H,以96%的收率获得产物克林前列素
      参考文献:Prostaglandin Synthesis. 14. A Controlled Synthesis Of Isocarbacyclin
      标题:Prostaglandin Synthesis. 14. A Controlled Synthesis Of Isocarbacyclin
      摘要:
      DOI:10.1021/jo00234A014

      海关参考信息

      专利信息


      专利号:US-2008287407-A1
      优先权日:2003-12-10
      标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
      发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
      权利人:NITROMED INC
      摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

      专利号:US-11384044-B2
      优先权日:2017-08-03
      标 题 :Method for introducing substituent into α,β-unsaturated ketone and method for synthesizing prostaglandin using the same
      发明人:SUZUKI MASAAKI; KOYAMA HIROKO
      权利人:NAT CT GERIATRICS & GERONTOLOGY
      摘要:The present invention provides a method for introducing substituents into the α-position and the β-position of an α,β-unsaturated ketone, which not only can be used for the synthesis of a prostaglandin by a three-component coupling process, but also enables synthesis of a prostaglandin in a high yield by one-pot operation without requiring the use of a large excess amount of any of the three components required for the synthesis or using a highly toxic heavy metal as a catalyst or a solvent that is highly toxic to living bodies, and a method for synthesizing a prostaglandin using the same technical means. n The method for introducing substituents into an α,β-unsaturated ketone according to the present invention is a method for introducing substituents into the carbon at the α-position and the carbon at the β-position of an α,β-unsaturated ketone, including: a first step of mixing alkyllithium and trialkylalkenyl tin in which tin atom binds to the vinyl position of the alkenyl group; a second step of mixing the mixture of the first step and dialkylzinc; a third step of mixing the mixture of the second step and an α,β-unsaturated ketone; and a fourth step of mixing the mixture of the third step and a trifluoromethanesulfonate compound.

      专利号:US-6653345-B2
      优先权日:1997-09-16
      标题 :C-C chemokine synthesis inhibitor
      发明人:KURUMATANI HAJIMU; SASAKI RIE; KUMAGAI HIROKI
      权利人:TORAY INDUSTRIES
      摘要:A method of inhibiting mammalian C-C chemokine production by using a mammalian C-C chemokine synthesis inhibitor containing a prostaglandin I derivative as an active component to treat a variety of circulatory diseases, inflammation, allergic diseases, and renal diseases.

      专利号:US-2014114086-A1
      优先权日:2012-10-22
      标 题:Clinprost, Isocarbacyclin And Analogs Thereof And Methods Of Making The Same
      发明人:CROATT MITCHELL
      权利人:UNIV NORTH CAROLINA AT GREENSBORO
      摘要:In one aspect, methods of synthesizing clinprost, isocarbacyclin and analogs thereof are described herein which, in some embodiments, permit an abbreviated synthetic pathway in comparison to one or more prior synthetic methods. By providing a compact synthetic scheme, methods described herein can reduce cost, waste and time of clinprost and isocarbacyclin synthesis while facilitating the development and investigation of analogs of these compounds.

      专利号:US-6087395-A
      优先权日:1997-10-21
      标题 :Isocarbacyclin derivatives as apoptosis inhibitors
      发明人:WATANABE YASUYOSHI; HAZATO ATSUO; SUZUKI MASAAKI; WATANABE YUMIKO; SATO TAKUMI
      权利人:JAPAN SCIENCE & TECH CORP; ATSUO HAZATO
      摘要:The present invention provides an apoptosis inhibitor containing a 15R-isocarbacyclin derivative or a 15-deoxy-isocarbacyclin derivative, which can be manufactured easily and economically by means of chemical synthesis.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Umekubo N, Hayashi Y. Pot-Economical Total Synthesis of Clinprost. Org Lett. 2020 Dec 4;22(23):9365-9370. doi: 10.1021/acs.orglett.0c03616. Epub 2020 Nov 24. 48(10):1016-22. doi: 10.1111/j.2042-7158.1996.tb05893.x. 3(3):CD011033. doi: 10.1002/14651858.CD011033.pub3. Update in: Cochrane Database Syst Rev. 2020 May 4;5:CD011033.
      4: Cacione DG, Macedo CR, do Carmo Novaes F, Baptista-Silva JC. Pharmacological treatment for Buerger's disease. Cochrane Database Syst Rev. 2020 May 4;5(5):CD011033. doi: 10.1002/14651858.CD011033.pub4.
      5: Nagy EE, Hyatt IF, Gettys KE, Yeazell ST, Frempong SK Jr, Croatt MP. Sequential Pd(0)-, Rh(I)-, and Ru(II)-catalyzed reactions in a nine-step synthesis of clinprost. Org Lett. 2013 Feb 1;15(3):586-9. doi: 10.1021/ol303402e. Epub 2013 Jan 17.

      合成参考文献


      摘要:Kiso to Rinsho. Clinical Report., 29(2961), 1995
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知